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The Latin American Dialysis and Renal Transplantation Reg-
istry Annual Report 2002. Latin America is a conglomerate of
adjacent countries having in common a Latin extraction and
language (Spanish or Portuguese) and exhibiting extreme vari-
ations in socioeconomic status. The Latin American Society of
Nephrology and Hypertension Dialysis and Renal Transplanta-
tion Registry was created in 1991. Annual data are sent by local
societies in 3 forms: patient, center, and country. The prevalence
of renal replacement therapy (RRT) (all modalities) increased
from 119 patients per million population (pmp) in 1991 to 349
pmp in 2001; the acceptance rate was 91.7 pmp in 2001. Dial-
ysis prevalence was 277 pmp; hemodialysis was the predomi-
nant modality, except in Mexico (86% on peritoneal dialysis).
The highest dialysis prevalence and acceptance rates were re-
ported by Puerto Rico, Uruguay, and Chile. Among incident
patients, diabetic nephropathy (33%) and nephroangioescle-
rosis (32%) were the primary causes; 38% were older than
65 years old. Renal transplants increased from 3.7 pmp in 1987
to 13.7 pmp in 2001. In 2003, 6357 transplants were performed
(55% living donor); the cumulative number performed since
1987 reached 55,947. Prevalence and incidence are low because
not all patients with end-stage renal disease have access to RRT
because of restricted availability, difficulties in referral, and in-
equities in coverage. The annual increase in the number of pa-
tients on RRT (8%–10%) is higher, proportionally, than the
annual growth of the Latin American population in general
(1.5%). Efforts must be focused on prevention and treatment
of chronic kidney disease, especially in diabetic and older pa-
tients, and in implementing better organ donation programs to
improve the pool of cadaveric donors.
Resumen
Ame´rica Latina es un conjunto de naciones que tienen en
comu´n su origen latino, su idioma (Espan˜ol o Portugue´s), ası´
como la grave desigualdad social y econo´mica de sus habitantes.
El Registro de Dia´lisis y Trasplante Renal de la SLANH se inicio´
en 1991. La informacio´n anual generada es enviada por las so-
ciedades de nefrologı´a locales en tres formularios: por paciente,
por centro y por paı´s. La prevalencia de pacientes en terapia de
reemplazo de la funcio´n renal (TRR) en todas sus formas, se
incremento´ de 119 pacientes por millo´n de habitantes (pmh)
en 1991 a 349 pmh en 2001; la tasa de aceptacio´n fue de 91.7
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pmh y la prevalencia en dia´lisis de 277 pmh en el an˜o 2001.
La hemodia´lisis es la forma de tratamiento ma´s utilizada, ex-
cepto en Me´xico, donde el 86% utiliza la dia´lisis peritoneal.
Las tasas ma´s altas de aceptacio´n y prevalencia se registran en
Puerto Rico, Uruguay y Chile. En los pacientes incidentes, la
nefropatı´a diabe´tica (33%) y la nefroesclerosis (32%), fueron
las causas ma´s frecuentes de falla renal; el 38% de ellos tenı´an
ma´s de 65 an˜os de edad. La frecuencia de trasplante renal se
incremento´ de 3.7 pmh en 1987 a 13.7 pmh en 2001. En este
u´ltimo an˜o se practicaron 6,357 trasplantes, el 55% de ellos de
donante vivo; la cifra acumulada desde 1987 alcanzo´ los 55,947
trasplantes practicados. La prevalencia e incidencia son bajas
debido que no todos los pacientes tienen acceso a la TRR; ya
sea por una disponibilidad limitada de programas. problemas
en la derivacio´n. El aumento anualizado en el nu´mero de pa-
cientes en TRR (8%-10%) es proporcionalmente mayor que
el crecimiento de la poblacio´n en general (1.5%) en la regio´n.
Nuestros esfuerzos se deben reorientar hacia la prevencio´n y
tratamiento de la enfermedad renal cro´nica, especialmente en
el paciente diabe´tico y el de mayor edad, ası´ como el establec-
imiento de mejores sistemas de procuracio´n de o´rganos para
aumentar el nu´mero de donantes cadave´ricos.
Latin America is a conglomerate of adjacent countries
which have in common a Latin extraction and language,
either Spanish or Portuguese. It comprises Mexico, in
North America, countries in Central and South America,
and the Spanish Islands of the Caribbean. It is a heteroge-
neous region, with countries that exhibit extreme varia-
tions in socioeconomic status. The gross national income
in 2001 was US $3550 per capita, but it ranged from 480 in
Haiti to 10,550 in Puerto Rico; total life expectancy was
70.5 years but, again, the range was wide, from 52.4 years
in Haiti, 63 in Bolivia, and 76 in Puerto Rico. Similar dif-
ferences can be seen in the human development index,
which was 0.777 for the whole region but varied from
0.467 in Haiti and 0.606 in Mexico to 0.849 in Argentina
[1, 2].
The Latin American population, estimated at
519,200,000 in 2001, increases 1.5% annually, and people
under 65 years of age make up 5.6% of the total [1]. Most
of the inhabitants are of Caucasian origin, descending
from Spanish and Portuguese. The aboriginal people
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Table 1. Distribution of aboriginal people in Latin America
Country No. of aboriginals Total population (%)
Bolivia 4,400,000 55
Peru 10,000,000 45
Guatemala 5,000,000 44
Mexico 30,000,000 30
Ecuador 3,500,000 25
El Salvador 300,000 5
Chile 450,000 3
Costa Rica 36,000 1
Argentina 1,000,000 3
sum about 40 million individuals, divided in more than
400 ethnic groups, and constitute 27% of the rural
population. In Bolivia, more than half of the total
population is indigenous. (Table 1) [3]. In Brazil, the
largest minority groups comprise blacks and mulattos
(45%), with indigenous people being less than 0.5%
[4].
The Latin American Society of Nephrology and Hyper-
tension (SLANH) is comprised of the National Societies
of Nephrology of 20 Latin American countries (Table 2);
these countries include a population of 509,565,697 in-
habitants. The SLANH Dialysis and Renal Transplanta-
tion Registry was created in 1991. Since then, 8 reports
have been published [5–13]. The data are collected, at
the request of the Coordinating Committee, from each
local society of nephrology. Many of these national reg-
istries are voluntary. Transplantation data are obtained
in conjunction with the Transplantation Society of Latin
America and the Caribbean, the society that maintains
the Latin American Transplantation Registry, under the
directorship of Eduardo Santiago Delpin and Valter
Duro Garcia (available at www.abto.org.br). Data are
gathered in 3 forms: patient, center, and country; the
database is updated every year.
Although limited, the information obtained by this reg-
istry has improved our knowledge of renal replacement
treatment (RRT) in Latin America, stimulated the devel-
opment of national registries, and allowed us to compare
the results of these therapies in patients of this region
with patients of other regions. The 2002 report includes
data from the years 2000 and 2001. Dialysis data were
obtained from 14 of the 20 countries (where 90% of the
SLANH population lives), whereas kidney transplanta-
tion data came from 18 of the 20 countries, where 96%
of the SLANH population is located. Trends in RRT are
also described in this report.
RRT in Latin American countries has shown a progres-
sive increase in the last 10 years (Fig. 1). The prevalence
of all treatment modalities increased from 119 patients
per million population (pmp) in 1991 to 349 pmp in 2001
(Fig. 1) [5–13].
According to information sent by each country, of
the 164,538 patients undergoing RRT as of December
31, 2001, 92,767 (56.4%) were on hemodialysis, 37,727
(23%) were on peritoneal dialysis, and 34,044 (20.7%)
were living with a functioning transplanted kidney.
(Table 2).
However, prevalence data on RRT must be interpreted
with caution because specific countries providing data in
each year are different, and the percentage of patients
on various types of RRT reported in each country is dif-
ferent from year to year. But if one takes into account
only countries that report every year (such as Argentina,
Chile, Uruguay, Venezuela, and Puerto Rico), the ascend-
ing trend in prevalence is similar. In fact, the only coun-
try that showed a tendency to level out in the last 4 re-
ports was Puerto Rico, with prevalence consistently over
950 pmp.
The prevalence rate of hemodialysis in the 14 coun-
tries that provided data (population of 461,913,654 in-
habitants) was 277.1 pmp in 2001. Hemodialysis was the
predominant modality, except in Mexico, where 86% of
the patients on dialysis were on peritoneal dialysis treat-
ment (Fig. 2). The highest prevalence rate of dialysis was
reported by Puerto Rico and Uruguay, with 843 and 689
pmp, respectively; prevalence rates in Argentina, Chile,
and Mexico ranged between 300 and 600 pmp. Only 2
countries, Costa Rica and Paraguay, had very low preva-
lence rates—under 100 pmp.
In these 14 countries, only 20.6% of the patients on
RRT had a functioning renal transplant (Fig. 3).
Given the large socioeconomic heterogeneity
(Table 2), it is not surprising that a linear correla-
tion can be observed between RRT and gross national
income per capita (in US dollars) (Fig. 4).
During 2001, the acceptance rate of new patients was
91.4 pmp in all countries, and with a wide variation
(Fig. 5). Puerto Rico, Chile, and Uruguay (298.5, 127.3
and 122.1 pmp, respectively) were the countries with the
highest acceptance rates, whereas Paraguay (25.6 pmp)
and Ecuador (9.6 pmp) had the lowest.
The number of new cases of patients with end-stage
renal disease (ESRD) continues to rise, from 27.8 pmp
in 1992 to 57 pmp in 1997 and 91.4 pmp in 2001. These
rates should be interpreted with caution, because only
9 countries provided data in 1992, 13 in 1997, and 14 in
2001.
Nevertheless, 2 trends can be observed in incident pa-
tients on dialysis: (1) Diabetic nephropathy has become
the primary cause of ESRD (33%) and is increasing
yearly (Figs. 6 and 7), being as high as 65.9% among
new patients in Puerto Rico [2–9]. Nephroangiosclerosis
comes in second at 32%. These two diagnoses accounted
for 65% of new patients with ESRD. (2) The number of
older patients initiating dialysis has continued to increase
with patients older than 65 years of age constituting more
than 38% of new patients. Patients 75 years and older are
increasing as well (Fig. 8).
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Table 2. Prevalence of RRT in Latin America (SLANH countries)
Prevalence
Total population Life Patients Patients Patients Prevalence
Country millions [1] expectancy [1] GNI [1] HDI [2] on HD on PD with grafts (pmp)
Argentina 36,26 74 7460 0.849 16200 500 4000 570,87
Bolivia 8,27 63 900 0.672 – – – –
Brazil 177,75 68 3610 0.777 43700 5106 14314 355,10
Chile 15,31 76 4810 0.831 7744 334 2066 662,64
Colombia 42,32 71 2020 0.779 4202 3593 1262 214,01
Costa Rica 3,90 77 3820 0.832 100 25 454 148,46
Cuba 11,25 76 5259 0.806 1150 100 814 183,45
Ecuador 12,20 70 3280 0.731 1325 168 168 3615
El Salvador 6,4 70 2000 0.719 – – – –
Guatemala 10,80 65 1690 0.652 547 793 328 154,44
Honduras 6,1 69 860 0.667
Mexico 97,48 73 5100 0.606 4162 25570 7015 376,96
Nicaragua 4,92 69 2450 0.643 – – – –
Panama 2,85 75 3920 0.788 – – – –
Paraguay 5,73 70 1520 0.751 347 80 74,47
Peru 26,10 69 2060 0.752 3191 481 1275 189,54
Puerto Rico 3,92 76 10550 0.737 2869 431 559 985,44
Dominican Republic 8,1 67 2120 0.737 – – – –
Uruguay 3,40 74 6600 0.834 2217 126 409 809,41
Venezuela 24,63 73 4310 0.775 5013 500 1300 276,62
Total 507,69 92767 37727 34044 349,30
Abbreviations are: RRT, renal replacement therapy; SLANH, Latin American Society of Nephrology and Hypertension; GNI, gross national income; HDI, human
development index; HD, hemodialysis; PD, peritoneal dialysis.
Note: Bolivia, El Salvador, Honduras, Panama, Dominican Republic, and Nicaragua did not report during the years of 2000 to 2001. Their previous known prevalence
was: Bolivia, 19.3 pmp in 1992; El Salvador, 55 pmp in 1995; Honduras, 32.8 pmp in 1997; Dominican Republic, 59.8 pmp in 1999 [13].
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Fig. 1. Prevalence of RRT (all modalities) from 1992 to 2001. The line
shows the trend and predicted prevalence in 2005.
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Fig. 2. Point prevalence of hemodialysis and peritoneal dialysis on De-
cember 31, 2001.
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Fig. 4. Linear correlation between gross national income (per capita
in US dollars) and prevalence of RRT in 2001 (all modalities).
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Fig. 7. Incident patients with diabetes, 1991–2001 (N = 18, 486 pa-
tients with incident). Black column is 2001 incidence, excluding Puerto
Rico. The line marks the trend.
These two tendencies are actually taking place all over
the world. Diabetic nephropathy accounts for 45% of new
patients in the United States [14], 25% in Australia, 37%
in New Zealand [15], 22.4% in the 2001 European Renal
Association-European Dialysis and Transplant Associa-
tion Report [16], and 36.6% in Japan [17]. Patients 65
years and older constitute 49.3% of incident cases in the
United States [14], 31% in Europe [16], 43% in Australia
[15], and 53% in Japan [17].
Vascular disease (cardiovascular or cerebrovascular)
was the major cause of death in patients on dialysis (40%
of total deaths), followed by infections (20%). With-
drawal from treatment was only 7% in the Latin Ameri-
can population (Fig. 9).
The adjusted mortality rate in Latin American coun-
tries was 26.4 per 100 patients per year in patients with
type 1 diabetes mellitus and significantly less in patients
without diabetes (12.4 by 100 patients per year) (Fig. 10)
[13].
Kidney transplantation has been performed in Latin
America for almost 45 years. Argentina conducted its
first transplantation in a patient in 1957, Mexico in 1963,
Brazil in 1964, and Colombia in 1965. Overall, kidney
transplants are performed in all 20 countries that consti-
tute the SLANH.
The increase in the number of renal transplants is
shown in Figure 11: from 3.7 pmp in 1987 to 13.7 pmp
in 2001. The highest transplant rates were reported in
Costa Rica (27.7 pmp), Uruguay (18.8 pmp), and Puerto
Rico (23.2 pmp). The total number of renal transplants
performed in 2001 was 6357. The cumulative number of
kidney transplants reached 55,947 in 2001 (Fig. 12). Brazil
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contributed nearly half of the renal transplants in the
region.
The number of deceased donor renal transplants has
grown over the last decade, but living donor transplants
predominated in 2001 (55%). However, in several coun-
tries, such us Argentina, Chile, Colombia, Cuba, Puerto
Rico, Uruguay, and Venezuela, deceased donor kidney
transplants exceeded living donor transplants.
Kidney-pancreas transplants are performed increas-
ingly for type 1 diabetic nephropathy in Argentina and
Brazil. Kidney-liver and kidney-heart transplants are also
occasionally performed (Table 3).
Infection continues to be the most frequent cause of
death in patients with kidney transplants (42%), followed
by cardiac causes (22%) (Fig. 13). [13]
There is no reason to presume that ESRD is less fre-
quent in Latin America than in other parts of the world.
Although there is probably a sub registry, low rates of
prevalence and incidence observed may be due to the
fact that, in many countries of the region, access to RRT
is limited. Data collected by the SLANH Registry in-
dicate that in Latin American countries RRT may not
reflect true ESRD incidence, because in many countries
there are not adequate resources to provide treatment for
ESRD. As shown in Figure 4, the richest countries have
higher ESRD prevalence rates.
Insurance coverage varies from country to country. In
Argentina, Chile, Cuba, Uruguay, Brazil, and Venezuela,
access to RRT is assured. But less than 20% and approx-
imately 30% of patients in Paraguay and Peru, respec-
tively, are covered by the social security system.
CONCLUSIONS
The rate of increase in the number of ESRD patients is
higher than that of the general population in Latin Amer-
ica (8%–10% per year vs. 1.5%). It is predicted that by
2005 the ESRD prevalence rate in the region will exceed
450 pmp.
Because diabetic nephropathy has become the primary
cause of ESRD, the number of new ESRD cases will con-
tinue to rise unless the prevalence of diabetes in the gen-
eral population is stabilized and treatment of diabetic
nephropathy is optimized. However, the segment of the
general population over 65 years old is increasing, and
they have a higher prevalence of chronic kidney disease.
Therefore, there is need for treatment approaches to pre-
vent or retard progression of kidney disease, thus reduc-
ing the number of patients that will need RRT in the
future.
Better organ procurement programs are needed to in-
crease the pool of kidneys available for transplantation.
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Table 3. Double organ transplantation in Latin America
Double transplantation 2000–01 Argentina Brazil Colombia Cuba
Kidney-pancreas 17 129 8 4
Kidney-liver 3 1
Kidney-heart 1 1
Cerebrovascular
1%
Cardiac
22%
Others
33%
Cancer
2%
Infectious
42%
Fig. 13. Causes of death in patients who underwent transplantations,
1993–1999.
Finally, differences in socioeconomic status lead to
unequal access to health care. Therefore, programs are
needed to extend full coverage to all who require RRT.
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